SCHEMBL21136711

SCHEMBL21136711

CC(C)(C)OC(=O)N1CCN(c2c(NC=O)cnc3c(F)c(Br)c(Cl)cc23)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK8 P45983 1/20 0.41
GPR119 Q8TDV5 4/20 0.39
KCNH2 Q12809 2/20 0.38
ALK Q9UM73 4/20 0.37
CCNK O75909 1/20 0.36
CCNA2 P20248 1/20 0.36
CDK2 P24941 1/20 0.36
CCND3 P30281 1/20 0.36
CDK9 P50750 1/20 0.36
CDK6 Q00534 1/20 0.36
MEN1 O00255 1/20 0.36
MAPT P10636 1/20 0.36
TSHR P16473 1/20 0.36
KMT2A Q03164 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
BACE1 P56817 2/20 0.36
NR1H2 P55055 1/20 0.36
NR1H3 Q13133 1/20 0.36
PGK1 P00558 1/20 0.36
KIT P10721 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21137556 0.88 GPR119 (0.41) MAPK8GPR119KCNH2ALKCCNK
SCHEMBL21136807 0.87 HDAC1 (0.39) GPR119MAPT
SCHEMBL20570346 0.84 NR1H2 (0.46) GPR119KCNH2NR1H2NR1H3
SCHEMBL16636900 0.84 MAPK8 (0.39) MAPK8GPR119KCNH2MEN1MAPT
SCHEMBL21137486 0.84 NR1H2 (0.37) MAPK8GPR119KCNH2ALKMEN1
SCHEMBL21136818 0.83 KCNH2 (0.40) MAPK8GPR119KCNH2CCNKCCNA2
SCHEMBL16636974 0.83 MAPK8 (0.39) MAPK8GPR119KCNH2MEN1MAPT
SCHEMBL21136735 0.82 KCNH2 (0.47) MAPK8GPR119KCNH2CDK9MEN1
SCHEMBL16637247 0.82 USP2 (0.49) MEN1MAPTKMT2A
SCHEMBL20571090 0.81 NR1H2 (0.43) GPR119KCNH2NR1H2NR1H3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019110751-A1 TETRACYCLIC COMPOUNDS AS INHIBITORS OF G12C MUTANT RAS PROTEIN, FOR USE AS ANTI-CANCER AGENTS ASTRAZENECA AB (SE) 2019-06-13 WO disclosed